
VolitionRx Limited VNRX
$ 0.2
-2.41%
Quarterly report 2025-Q3
added 11-13-2025
VolitionRx Limited P/S Ratio 2011-2026 | VNRX
Annual P/S Ratio VolitionRx Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 44.4 | 75 | 291 | 1.74 K | - | 10.8 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10.8 K | 44.4 | 2.59 K |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Anixa Biosciences
ANIX
|
0.718 | $ 2.89 | -2.36 % | $ 93.8 K | ||
|
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
6.64 | $ 118.67 | 0.46 % | $ 36.1 B | ||
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M | ||
|
Castle Biosciences
CSTL
|
2.14 | $ 27.81 | -0.64 % | $ 772 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M | ||
|
Charles River Laboratories International
CRL
|
1.92 | $ 177.9 | -0.41 % | $ 8.82 B | ||
|
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | ||
|
Fulgent Genetics
FLGT
|
1.65 | $ 14.03 | -1.23 % | $ 424 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | ||
|
Biodesix
BDSX
|
1.29 | $ 15.96 | 1.3 % | $ 2.07 B | ||
|
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
0.115 | $ 1.1 | -3.49 % | $ 1.4 M | ||
|
Quest Diagnostics Incorporated
DGX
|
2.11 | $ 208.55 | -0.82 % | $ 23.1 B | ||
|
Danaher Corporation
DHR
|
6.09 | $ 202.93 | -1.44 % | $ 145 B | ||
|
Exact Sciences Corporation
EXAS
|
6 | $ 103.39 | 0.04 % | $ 19.5 B | ||
|
Bioventus
BVS
|
0.685 | $ 8.85 | 0.91 % | $ 554 M | ||
|
DarioHealth Corp.
DRIO
|
2.13 | $ 10.5 | -2.33 % | $ 298 M | ||
|
DexCom
DXCM
|
5.47 | $ 72.97 | -1.1 % | $ 28.5 B | ||
|
QIAGEN N.V.
QGEN
|
5.03 | - | - | $ 10.6 B | ||
|
Burning Rock Biotech Limited
BNR
|
6.87 | $ 24.2 | -3.82 % | $ 254 M | ||
|
CareDx, Inc
CDNA
|
2.61 | $ 18.66 | -0.45 % | $ 994 M | ||
|
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | ||
|
ICON Public Limited Company
ICLR
|
3.25 | $ 108.73 | 0.42 % | $ 8.97 B | ||
|
IDEXX Laboratories
IDXX
|
11.9 | $ 635.4 | -0.2 % | $ 51.1 B | ||
|
Illumina
ILMN
|
3.75 | $ 130.82 | -1.55 % | $ 20.8 B | ||
|
Guardant Health
GH
|
13.7 | $ 93.48 | 1.35 % | $ 11.7 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.71 | $ 283.3 | -1.03 % | $ 23.6 B | ||
|
IQVIA Holdings
IQV
|
1.74 | $ 174.31 | 0.02 % | $ 30 B | ||
|
Lantheus Holdings
LNTH
|
3.32 | $ 78.0 | 2.23 % | $ 5.26 B | ||
|
Brainsway Ltd.
BWAY
|
8.09 | $ 23.0 | -2.91 % | $ 99.4 M | ||
|
Co-Diagnostics
CODX
|
5.13 | - | - | $ 79.8 M | ||
|
Mettler-Toledo International
MTD
|
7.06 | $ 1 317.07 | -0.45 % | $ 27.1 B | ||
|
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | ||
|
Myriad Genetics
MYGN
|
0.496 | $ 5.26 | 4.99 % | $ 487 M | ||
|
NeoGenomics
NEO
|
2.04 | $ 9.5 | - | $ 1.22 B | ||
|
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
6.47 | $ 208.69 | 4.26 % | $ 20.5 B | ||
|
Pacific Biosciences of California
PACB
|
3.11 | $ 1.54 | -4.94 % | $ 462 M | ||
|
Neogen Corporation
NEOG
|
1.14 | $ 11.01 | -1.3 % | $ 2.39 B | ||
|
Precipio
PRPO
|
0.572 | $ 24.5 | -0.73 % | $ 31.8 M | ||
|
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M |